Disc Medicine IRON
NASDAQ IRON
$74.51 -0.52 (-0.69%)
At close: Oct 23, 2026 · 4:00 PM EDT

Disc Medicine (IRON) Sale and Maturity of Investments (2024 - 2026)

Updated

Analysis

Disc Medicine (IRON) Sale and Maturity of Investments (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Disc Medicine 2.86 Bn 2.16 Mn - 114.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 114.36 Mn
Mar 31, 2026 152.07 Mn
Dec 31, 2025 135.40 Mn
Sep 30, 2025 135.00 Mn
Jun 30, 2025 110.35 Mn
Mar 31, 2025 75.47 Mn
Dec 31, 2024 71.80 Mn
Sep 30, 2024 23.00 Mn
API Access

Disc Medicine Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=IRON&period=max&api_key=YOUR_API_KEY